Oppenheimer Initiates Coverage On Guardian Pharmacy Service with Outperform Rating, Announces Price Target of $30
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Oppenheimer analyst Michael Wiederhorn initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Outperform rating and announces Price Target of $30.
Oppenheimer analyst Michael Wiederhorn initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Outperform rating and announces Price Target of $30.